Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
前日終値
$366.16
+$5.76 · +1.60%
日中の時刻はETです。市場データは遅延する場合があります。
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
日中レンジ
現在 $366.16
52週レンジ
現在 $366.16
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
64
割安
センチメント
66
強気
リスク
36
中程度のリスク
モメンタム
42
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
日中レンジ
現在 $366.16
52週レンジ
現在 $366.16
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 25.83億 USD | 25.67億 USD | 26.71億 USD | 28.02億 USD | 29.23億 USD |
| 売上原価 | 12.4億 USD | 11.88億 USD | 12.44億 USD | 12.35億 USD | 12.84億 USD |
| 粗利益 | 13.44億 USD | 13.79億 USD | 14.27億 USD | 15.67億 USD | 16.38億 USD |
| 研究開発 | 2.57億 USD | 2.96億 USD | 2.47億 USD | 2.57億 USD | 2.61億 USD |
| 販売・一般管理 | 8.2億 USD | 8.14億 USD | 8.42億 USD | 8.28億 USD | 8.77億 USD |
| 営業費用 | 10.78億 USD | 11.1億 USD | 10.89億 USD | 10.85億 USD | 11.38億 USD |
| 受取利息 | 9550万 USD | 8200万 USD | 1.01億 USD | 5800万 USD | 1890万 USD |
| 支払利息 | 4900万 USD | 4890万 USD | 4943.9万 USD | 3811.4万 USD | 155.1万 USD |
| 減価償却費と償却費 | 1.65億 USD | 1.52億 USD | 1.46億 USD | 1.37億 USD | 1.38億 USD |
| 営業利益 | 2.71億 USD | 2.69億 USD | 3.38億 USD | 4.83億 USD | 5億 USD |
| 純利益 | 7.6億 USD | −18.44億 USD | −6.37億 USD | −36.28億 USD | 42.54億 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$350
下落余地(4.41%)| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2002年3月8日 | 2:1 | — | — |
株式分割 | 1996年6月3日 | 3:2 | — | — |
株式分割 | 1986年6月11日 | 3:2 | — | — |
株式分割 | 1985年8月1日 | 3:2 | — | — |
株式分割 | 1980年3月18日 | 2:1 | — | — |
発効済み 2002年3月8日
2:1
発効済み 1996年6月3日
3:2
発効済み 1986年6月11日
3:2
発効済み 1985年8月1日
3:2
発効済み 1980年3月18日
2:1
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI2.26億0.01%2.3兆 USD0.03%$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB1.64億0.09%1853億 USD0.03%$289.48+0.64%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1.48億0.55%268.09億 USD0.33%$37.95-0.39%
Vanguard Morningstar Small-Cap Value ETFVBR1.04億0.15%682億 USD0.05%$234.43+0.22%
Vanguard Extended Market ETFVXF8086.4万0.08%954億 USD0.05%$235+0.80%
Dimensional - US Small Cap ETFDFAS5290.85万0.16%338.69億 USD0.31%$78.35+0.32%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY4875.62万0.19%255.83億 USD0.23%$669.87+0.54%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD3511.81万0.19%182.7億 USD0.03%$64.33+0.56%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
State Street SPDR S&P MIDCAP 400 ETF TrustMDY
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMDAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。